Trial intelligence / Profile preview

BCG vaccination to prevent infections after open abdominal surgery

NL-OMON25596Not yet recruiting

Sponsor
Radboud University Medical Center
Start
Nov 2018
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Randomised, double-blind trial in surgical site infection (SSI), pneumonia, sepsis and 2 more comparing BCG vaccination with Placebo vaccination (2 arms). Primary endpoint: Immune cell function after BCG vaccination and after surgery. Planned start Nov 2018; status: not yet recruiting.

02

Drugs

bcg vaccine
03

Conditions

surgical site infection (SSI)pneumoniasepsisurinary tract infection (UTI)postoperative ileus (POI)

Beyond the preview

Go deeper on NL-OMON25596.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON25596.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call